JAKARTA (Yosefardi) – Pharmaceutical company PT Daria-Varia Laboratoria Tbk (DVLA) plans to merge with PT Pradja Pharin (Prafa). The merger is targeted to be effective by June 30, 2014.
DVLA now has 2 global-scale manufacturing facilities in Gunung Putri (Bogor) and Citeureup. By end 2013, its production capacity totaled 1.05 billion units of soft capsules.
DVLA’s assets totaled Rp1.12 trillion and liability reached Rp229.24 billion. It booked net profit of Rp118.89 billion in 2013 on sales of Rp1.02 trillion.
While Prafa’s assets totaled Rp215.79 billion and liability reached Rp58.47 billion. It booked net profit of Rp34.83 billion last year on sales of Rp217.93 billion.